Tuesday, 26 October 2010

Hanalgeze




Hanalgeze may be available in the countries listed below.


Ingredient matches for Hanalgeze



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Hanalgeze in the following countries:


  • Peru

International Drug Name Search

Thursday, 21 October 2010

Beta-Val Cream


Pronunciation: bay-ta-METH-a-sone VAL-eh-rate
Generic Name: Betamethasone Valerate
Brand Name: Beta-Val


Beta-Val Cream is used for:

Reducing itching, redness, and swelling associated with many skin conditions.


Beta-Val Cream is a topical corticosteroid. It works by depressing the formation, release, and activity of different cells and chemicals that cause swelling, redness, and itching.


Do NOT use Beta-Val Cream if:


  • you are allergic to any ingredient in Beta-Val Cream

Contact your doctor or health care provider right away if any of these apply to you.



Before using Beta-Val Cream:


Some medical conditions may interact with Beta-Val Cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have thinning of the skin, a skin infection, tuberculosis (TB), chickenpox, shingles, measles, or a positive TB skin test, or have recently been vaccinated

Some MEDICINES MAY INTERACT with Beta-Val Cream. Because little, if any, of Beta-Val Cream is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Beta-Val Cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Beta-Val Cream:


Use Beta-Val Cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Do not mix Beta-Val Cream with other medications.

  • Apply a small amount of medicine to the affected area. Gently rub the medicine in until it is evenly distributed. Wash your hands after applying Beta-Val Cream, unless your hands are part of the treated area.

  • Do not cover the areas being treated with bandages or other dressings unless advised to do so by your doctor.

  • If you miss a dose of Beta-Val Cream, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Beta-Val Cream.



Important safety information:


  • Avoid long-term use, especially near the eyes, on the face, on the genital and rectal areas, and in skin folds.

  • Beta-Val Cream is for external use only. Avoid contact with eyes or eyelids. If you get Beta-Val Cream in your eyes, immediately flush with cool tap water.

  • Do not use Beta-Val Cream for other skin conditions at a later time.

  • If Beta-Val Cream was prescribed to treat the diaper area of a child, avoid using tight-fitting diapers or plastic pants.

  • Beta-Val Cream should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Beta-Val Cream while you are pregnant. It is not known if Beta-Val Cream is found in breast milk. If you are or will be breast-feeding while you use Beta-Val Cream, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Beta-Val Cream:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Acne; cracking and stinging of the skin; dryness; excessive hair growth; inflamed hair follicles; itching; skin irritation.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); itching, burning, redness, or swelling not present before the use of Beta-Val Cream; secondary infection; skin thinning and discoloration.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Beta-Val side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center ( http://www.aapcc.org), or emergency room immediately. Beta-Val Cream may be harmful if swallowed.


Proper storage of Beta-Val Cream:

Store Beta-Val Cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Beta-Val Cream out of the reach of children and away from pets.


General information:


  • If you have any questions about Beta-Val Cream, please talk with your doctor, pharmacist, or other health care provider.

  • Beta-Val Cream is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Beta-Val Cream. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Beta-Val resources


  • Beta-Val Side Effects (in more detail)
  • Beta-Val Use in Pregnancy & Breastfeeding
  • Beta-Val Drug Interactions
  • Beta-Val Support Group
  • 0 Reviews for Beta-Val - Add your own review/rating


Compare Beta-Val with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Dermatological Disorders
  • Lichen Planus
  • Lichen Sclerosus

Sunday, 17 October 2010

Cétirizine Sandoz




Cétirizine Sandoz may be available in the countries listed below.


Ingredient matches for Cétirizine Sandoz



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cétirizine Sandoz in the following countries:


  • France

International Drug Name Search

Monday, 11 October 2010

Metohexal retard




Metohexal retard may be available in the countries listed below.


Ingredient matches for Metohexal retard



Metoprolol

Metoprolol succinate (a derivative of Metoprolol) is reported as an ingredient of Metohexal retard in the following countries:


  • Austria

International Drug Name Search

Moxaverine Hydrochloride




Moxaverine Hydrochloride may be available in the countries listed below.


Ingredient matches for Moxaverine Hydrochloride



Moxaverine

Moxaverine Hydrochloride (BANM) is also known as Moxaverine (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 8 October 2010

Norsulin




Norsulin may be available in the countries listed below.


Ingredient matches for Norsulin



Gliclazide

Gliclazide is reported as an ingredient of Norsulin in the following countries:


  • Poland

International Drug Name Search

Thursday, 7 October 2010

Vinorelbine




In the US, Vinorelbine (vinorelbine systemic) is a member of the drug class mitotic inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

  • Vinorelbine

  • Vinorelbine Intravenous

  • Vinorelbine Tartrate

UK matches:

  • Vinorelbine 10mg/ml concentrate for solution for infusion (Actavis UK Ltd)
  • Vinorelbine 10 mg/ml Concentrate for solution for infusion (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01CA04

CAS registry number (Chemical Abstracts Service)

0071486-22-1

Chemical Formula

C45-H54-N4-O8

Molecular Weight

778

Therapeutic Category

Antineoplastic agent, microtubule inhibitor

Chemical Name

3',4'-Didehydro-4'-deoxy-8'-norvincaleukoblastine

Foreign Names

  • Vinorelbinum (Latin)
  • Vinorelbin (German)
  • Vinorelbine (French)
  • Vinorelbina (Spanish)

Generic Names

  • Vinorelbine (OS: DCF, BAN)
  • 5'-Noranhydrovinblastine (IS)
  • KW 2307 (IS)
  • Vinorelbine (PH: USP 28)
  • Vinorelbine Tartrate (OS: BANM, USAN)
  • Didehydrodeoxynorvincaleukoblastine (IS)
  • Vinorelbin bitartrate (IS)
  • Vinorelbine Tartrate (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Vinorelbini tartras (PH: Ph. Eur. 6)

Brand Names

  • Eunexon
    AC Farma, Peru


  • Maverex
    Verofarm, Russian Federation


  • Navelbine
    PF, Luxembourg; Pierre Fabre, Germany; Pierre Fabre, Denmark; Pierre Fabre, Spain; Pierre Fabre, Israel; Pierre Fabre, Poland; Pierre Fabre, Romania; Pierre Fabre, Singapore; Pierre Fabre, Tunisia; Pierre Fabre, Turkey; Pierre Fabre Medicament, Slovenia


  • Navirel
    Medac, Czech Republic; Medac, Germany


  • Tevarelbine
    Pharmachemie, Bulgaria


  • Vilbine
    Richmond, Peru


  • Vilne
    Dosa, Argentina


  • Vinelbine
    Dabur, Georgia


  • Vinorayne
    Hospira, Poland


  • Vinorelbin Hexal
    Hexal, Germany


  • Vinorelbin Hospira
    Hospira, Hungary


  • Vinorelbin Sindan
    Sindan, Romania


  • Vinorelbina Ferrer Farma
    Ferrer, Spain


  • Vinorelbina Sandoz
    Sandoz, Colombia


  • Vinorelbina
    Biocrom, Peru


  • Vinorelbine Biocrom
    Biocrom, Argentina


  • Bagovir
    Armstrong, Mexico


  • Bendarelbin
    Bendalis, Germany


  • Eberelbin
    Ebewe, Austria


  • Filcrin
    Filaxis, Argentina


  • Min Nuo Bin
    Minsheng, China


  • Navelbin
    Pierre Fabre, Hungary


  • Navelbine
    Baxter, Chile; Baxter, Philippines; Boehringer Ingelheim, Austria; GlaxoSmithKline, Guyana; Kyowa Hakko Kirin, Japan; Orient Europharma, Taiwan; Pierre Fabre, Argentina; Pierre Fabre, Australia; Pierre Fabre, Belgium; Pierre Fabre, Canada; Pierre Fabre, China; Pierre Fabre, Czech Republic; Pierre Fabre, Germany; Pierre Fabre, Denmark; Pierre Fabre, Estonia; Pierre Fabre, Finland; Pierre Fabre, United Kingdom; Pierre Fabre, Georgia; Pierre Fabre, Greece; Pierre Fabre, Iceland; Pierre Fabre, Italy; Pierre Fabre, Lithuania; Pierre Fabre, Latvia; Pierre Fabre, Malta; Pierre Fabre, Netherlands; Pierre Fabre, Norway; Pierre Fabre, Oman; Pierre Fabre, Poland; Pierre Fabre, Romania; Pierre Fabre, Russian Federation; Pierre Fabre, Sweden; Pierre Fabre, United States; Pierre Fabre, Vietnam; Pierre Fabre Medicament, Slovakia; Pierre Fabre Médicament, France; Pierre-Fabre, Mexico; Robapharm, Switzerland; Tema Medical, South Africa; Transfarma Medica Indah, Indonesia


  • Navildez
    Cryopharma, Mexico


  • Navin
    Cancernova, Germany


  • Navirel
    Medac, Denmark; Medac, Finland; Medac, Netherlands; Medac, Norway; Medac, Poland; Medac, Sweden; Medac, Slovakia


  • Neocitec
    Novartis, Brazil; Sandoz, Argentina


  • Nibrevin
    Ingers, Czech Republic


  • Norelbin
    Eurofarma, Brazil


  • Riborelbin
    Ribosepharm, Germany


  • Sulcoline
    Teva, Argentina


  • Vinarine
    LKM, Argentina


  • Vinelbine
    Dabur, India; Dabur, Myanmar


  • Vinorelbin Actavis
    Actavis, Sweden


  • Vinorelbin Caduceus
    Caduceus Pharma, Slovakia


  • Vinorelbin cell pharm
    Cell pharm, Germany


  • Vinorelbin DRAC
    Dermapharm, Switzerland


  • Vinorelbin Ebewe
    Alliance, Poland; Ebewe, Czech Republic; Ebewe, Estonia; Ebewe, Hungary; Ebewe, Lithuania; Ebewe, Latvia; Ebewe, Slovenia; Ebewe Pharma, Denmark; Ebewe Pharma, Slovakia; Meda, Sweden; Sandoz, Switzerland


  • Vinorelbin Hospira
    Hospira Nordic, Sweden


  • Vinorelbin Mayne
    Hospira, Norway


  • Vinorelbin Medac
    Medac, Austria; Medac, Hungary


  • Vinorelbin NC
    NeoCorp, Germany


  • Vinorelbin Sandoz
    Sandoz, Austria; Sandoz, Slovakia


  • Vinorelbina Varifarma
    Varifarma, Argentina


  • Vinorelbina
    Kampar, Chile


  • Vinorelbin-Actavis
    Actavis, Austria; Actavis, Switzerland; Actavis, Germany


  • Vinorelbine ActavisGroup
    Actavis Group, Netherlands


  • Vinorelbine All-Gen
    All-Gen, Netherlands


  • Vinorelbine Ebewe
    Ebewe, France; Ebewe, Netherlands; InterPharma, New Zealand


  • Vinorelbine Hospira
    Hospira, Netherlands


  • Vinorelbine Mayne
    Faulding, France


  • Vinorelbine PCH
    Pharmachemie, Netherlands


  • Vinorelbine Sandoz
    Sandoz, Netherlands


  • Vinorelbine Tartrate
    Actavis, United States; APP, United States; Baxter, United States; Bedford, United States; Ebewe, United States; Hospira, Canada; Hospira, United States; Mayne, United States; Novopharm, Canada; Sicor, United States; Teva USA, United States


  • Vinorelbine Teva
    Teva, Latvia; Teva Santé, France


  • Vinorelbine
    Delta Farma, Argentina; Hospira, Australia; Mayne, Hong Kong; Medac, United Kingdom


  • Vinorgen
    Bioprofarma, Argentina


  • Vinotel
    Dabur, Philippines

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Ondeton




Ondeton may be available in the countries listed below.


Ingredient matches for Ondeton



Ondansetron

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondeton in the following countries:


  • Greece

International Drug Name Search

Dextropirine




Dextropirine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dextropirine



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Dextropirine in the following countries:


  • France

International Drug Name Search

Tuesday, 5 October 2010

Carncide




Carncide may be available in the countries listed below.


Ingredient matches for Carncide



Diethylcarbamazine

Diethylcarbamazine is reported as an ingredient of Carncide in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 4 October 2010

Effizinc




Effizinc may be available in the countries listed below.


Ingredient matches for Effizinc



Zinc Gluconate

Zinc Gluconate is reported as an ingredient of Effizinc in the following countries:


  • France

  • Luxembourg

International Drug Name Search

Saturday, 2 October 2010

Verum




Verum may be available in the countries listed below.


Ingredient matches for Verum



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Verum in the following countries:


  • Colombia

International Drug Name Search